Health

Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the US

April 22, 2026 1,485 views 1 min read
Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the US

Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the US


Lupin Limited (Lupin) has announced the launch of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, 10 mg/1,000 mg in the United States following the approval for its Abbreviated New Drug Application from the U.S. FDA as bioequivalent to Xigduo® XR for the indications in the approved labeling.

Tags